FDA's New Guidance Proposes Flexible Use Of AI In Medical Devices - Healthcare
That is, the algorithm is essentially locked and cannot change while out in the market, defeating the optimization of AI/ML technology.
United Kingdom Regulatory Agency Software Functions Draft Guidance Drug Administration Ai Software Predetermined Change Control Plan
Source: mondaq.com